僅用于工業應用或科學研究，不可用于人類或動物的臨床診斷或治療，非藥用. Pasotuxizumab （BAY 2010112） is a PSMA and CD3 bispecific T-cell engager （BiTE）. Pasotuxizumab binds to CD3 and PSMA with KDs of 9.4 nM and 47.0 nM for human CD3 and PSMA. Pasotuxizumab can be used for research of metastatic castration-resistant prostate cancer （mCRPC）